The Role of Chemotherapy in the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): The Large Experience of the Spanish National Tumor Registry (RGETNE)
Introduction: GEPNETs represent a heterogenous family of tumors of challenging clinical management. Treatment of advanced disease is evolving, including some recent relevant achievements with novel targeted agents. How to best integrate these new agents with conventional chemotherapy(CT) is still a matter of debate.
Aim(s): To assess by current standardized criteria the outcome of GEPNETs treated with CT in a large community setting
Materials and methods: RGETNE is a prospective national registry that comprises 103 hospitals representing all regions of Spain. Data is provided online at www.retegep.net by participating centers and assessed for internal consistency by external independent reviewers.
Conference: 9th Annual ENETSConcerence (2012)
To read the full abstract, please log into your ENETS Member account.